Intellectual Disability and Depression — MRCPsych Paper B MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Aim for the lowest effective dose, balancing adverse effects against undertreatment
The correct answer is D. NICE advises aiming for the lowest effective dose when choosing the initial dose and subsequent increases in people with learning disabilities. Prescribers should consider adverse effects and the person’s possible difficulty recognising or communicating them, while avoiding subtherapeutic dosing that leaves depression inadequately treated. NICE does not mandate a universally lower-than-usual starting dose, a fixed dose reduction or slower titration for every patient. Learning disability does not contraindicate SSRIs or antidepressant treatment generally, and tricyclic antidepressants are not preferred solely because a person has a learning disability. Treatment should otherwise follow the relevant NICE guideline for depression, with individualised monitoring and review.
Reference: National Institute for Health and Care Excellence. Mental health problems in people with learning disabilities: prevention, assessment and management. NICE guideline NG54, recommendations 1.9.1 and 1.9.5. 2016; reviewed 2024. https://www.nice.org.uk/guidance/ng54/chapter/Recommendations